Kirloskar Oil Engines Limited (NSE:KIRLOSENG)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 8, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	131,447	104,493	124,583	57,333	19,082	23,659
Market Cap Growth	-38.83%	-16.13%	117.30%	200.46%	-19.35%	88.26%
Enterprise Value	176,676	145,788	151,037	74,194	24,072	20,243
Last Close Price	904.85	716.61	849.69	388.37	126.44	153.52
PE Ratio	28.18	21.36	28.19	17.25	10.93	12.14
Forward PE	21.54	18.29	26.83	19.54	8.22	12.16
PS Ratio	2.02	1.65	2.11	1.14	0.47	0.72
PB Ratio	4.30	3.42	4.68	2.49	0.92	1.23
P/TBV Ratio	4.82	3.83	5.30	2.86	1.07	1.47
PEG Ratio	1.35	0.90	1.25	1.19	0.51	0.76
EV/Sales Ratio	2.72	2.30	2.56	1.48	0.60	0.61
EV/EBITDA Ratio	14.94	12.55	15.00	10.27	5.99	5.31
EV/EBIT Ratio	16.51	13.86	16.59	11.73	7.72	6.66
Debt / Equity Ratio	1.98	1.98	1.63	1.45	0.94	0.44
Debt / EBITDA Ratio	5.12	5.12	4.26	4.56	4.82	2.19
Asset Turnover	-	0.68	0.79	0.86	0.91	1.00
Inventory Turnover	-	5.91	5.97	6.77	6.95	5.30
Quick Ratio	-	1.07	0.84	1.10	1.29	1.49
Current Ratio	-	1.27	1.05	1.36	1.55	1.83
Return on Equity (ROE)	-	16.65%	17.72%	15.13%	8.54%	10.76%
Return on Assets (ROA)	-	7.01%	7.58%	6.73%	4.42%	5.79%
Return on Capital (ROIC)	8.30%	8.16%	9.00%	8.16%	5.72%	8.08%
Return on Capital Employed (ROCE)	-	15.00%	19.20%	15.10%	9.60%	11.90%
Earnings Yield	3.59%	4.68%	3.55%	5.80%	9.15%	8.24%
FCF Yield	-	-10.02%	-6.93%	-18.87%	-61.12%	-5.13%
Dividend Yield	0.71%	0.91%	0.71%	1.29%	3.16%	2.61%
Payout Ratio	-	17.80%	16.39%	21.76%	33.14%	11.13%
Buyback Yield / Dilution	0.02%	-0.08%	-0.18%	-0.14%	-0.14%	-
Total Shareholder Return	0.73%	0.82%	0.53%	1.15%	3.02%	2.61%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.